MetaCap

Who Owns Hemab Therapeutics Stock?

NASDAQ: COAGHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

39.29-0.57 (-1.43%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
97.98%
Institutional holders
115
  • Institutions 89.0%
  • Insiders 11.0%
  • Public and other 0.0%

Who owns Hemab Therapeutics stock?

Institutional investors own about 98.0% of Hemab Therapeutics's shares, spread across 115 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 11.00% of COAG.

The largest institutional holders are RA Capital Management, L.P. (16.71%), Novo Holdings A/S (8.95%) and FMR, LLC (7.97%). Together, the top 10 institutions control 66.8% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their COAG positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of COAG

Hemab Therapeutics top institutional holders
InstitutionShares% HeldChange
RA Capital Management, L.P.7.81M16.71%+100.0%
Novo Holdings A/S4.18M8.95%+100.0%
FMR, LLC3.72M7.97%+0.7%
Deep Track Capital, Lp3.60M7.71%+100.0%
Capital International Investors3.60M7.71%-0.1%
Siren, L.L.C.2.37M5.06%+13.4%
Avoro Capital Advisors LLC1.93M4.12%+100.0%
Bain Capital Life Sciences Investors, LLC1.65M3.53%+100.0%
Blackrock Inc.1.40M2.99%+392.9%
JPMORGAN CHASE & CO932.86K2.00%-19.1%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of COAG

Hemab Therapeutics top fund holders
FundShares% Held
SmallCap World Fund Inc3.51M7.50%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund555.54K1.19%
JPMorgan Trust II-JPMorgan Small Cap Growth Fund531.38K1.14%
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund523.85K1.12%
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF514.86K1.10%
iShares Trust-iShares Russell 2000 ETF506.79K1.08%
Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund383.45K0.82%
Fidelity Select Portfolios-Select Biotechnology Portfolio366.38K0.78%
Fidelity Securities Fund-Fidelity Blue Chip Growth Fund236.20K0.51%
Fidelity Securities Fund-Fidelity Series Small Cap Opportunities Fund215.15K0.46%

Frequently asked questions

Who is the largest shareholder of Hemab Therapeutics?

RA Capital Management, L.P. is the largest institutional shareholder of COAG, owning 16.71% of shares outstanding (7.81M shares) as of its latest 13F filing.

What percentage of Hemab Therapeutics is owned by institutions?

Institutions own about 98.0% of COAG shares and 110.1% of the public float.

How much of Hemab Therapeutics do insiders own?

Insiders, such as officers and directors, own about 11.00% of COAG shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related